HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Precision Age Delay Tri-Complex Prevents Collagen Breakdown - Chanel VP

This article was originally published in The Rose Sheet

Executive Summary

Chanel Precision Age Delay Rejuvenation Serum helps skin appear "biologically younger" with a triple-action complex to reduce collagen breakdown, add elasticity and "rejuvenate" the skin, the company announced at a press event in New York City May 3.

You may also be interested in...



FDA Approval Is "First Action" For 32% Of NMEs; Rate Less Than Other NDAs

FDA approved approximately one-third of new molecular entities with user fee deadlines in 2002 on the first cycle.

Chanel Precision Trio Combats "First Signs" Of Aging In Younger Consumers

Chanel Skin Conscience Total Health moisturizers will be added to the Precision skin care line to target younger consumers who may have concerns about the "first signs" of aging, the company said at a press event in New York City Oct. 24. Aimed at consumers 35 and younger, the new cream, lotion and oil-free lotion will bow in May.

Chanel Precision Trio Combats "First Signs" Of Aging In Younger Consumers

Chanel Skin Conscience Total Health moisturizers will be added to the Precision skin care line to target younger consumers who may have concerns about the "first signs" of aging, the company said at a press event in New York City Oct. 24. Aimed at consumers 35 and younger, the new cream, lotion and oil-free lotion will bow in May.

Latest News
See All
UsernamePublicRestriction

Register

RS007977

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel